Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131 I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer-论文-万方医学网

Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131 I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer

导出原文传递

翻译打印收藏纠错

作者： Park, Sohyun ; Bang, Ji-In ; Kim, Keunyoung ; Seo, Youngduk ; Chong, Ari ; Hong, Chae Moon ; Lee, Dong-Eun ; Choi, Miyoung ; Lee, Sang-Woo ; Oh, So Won

关键词 ATA high risk meta-analysis metastasis rhTSH thyroid cancer QUALITY-OF-LIFE RADIOIODINE REMNANT ABLATION LOW-DOSE RADIOIODINE RADIOACTIVE IODINE HUMAN TSH HUMAN THYROTROPIN CARCINOMA RHTSH METASTASES STRATEGIES

发布时间 2024-04-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131 I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131 I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer

相似文献

相关期刊

检索历史清除